Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification

MLA

Zhongwen Lu, et al. “Multi-Omics and Immunogenomics Analysis Revealed PFKFB3 as a Targetable Hallmark and Mediates Sunitinib Resistance in Papillary Renal Cell Carcinoma: In Silico Study with Laboratory Verification.” European Journal of Medical Research, vol. 29, no. 1, Apr. 2024, pp. 1–20. EBSCOhost, https://doi.org/10.1186/s40001-024-01808-5.

APA

Zhongwen Lu, Yongsheng Pan, Songbo Wang, Jiajin Wu, Chenkui Miao, & Zengjun Wang. (2024). Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification. European Journal of Medical Research, 29(1), 1–20. https://doi.org/10.1186/s40001-024-01808-5

Chicago

Zhongwen Lu, Yongsheng Pan, Songbo Wang, Jiajin Wu, Chenkui Miao, and Zengjun Wang. 2024. “Multi-Omics and Immunogenomics Analysis Revealed PFKFB3 as a Targetable Hallmark and Mediates Sunitinib Resistance in Papillary Renal Cell Carcinoma: In Silico Study with Laboratory Verification.” European Journal of Medical Research 29 (1): 1–20. doi:10.1186/s40001-024-01808-5.